BSEBoard Meeting4d ago · 1 Aug 2026, 03:41 pm
Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Unaudited ....
Venmax Drugs and Pharmaceuticals Ltd · 531015
✦ AI SummaryResults
Venmax Drugs and Pharmaceuticals Ltd has scheduled a board meeting on August 7, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026, and to consider the forfeiture of partly paid-up share warrants.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026.
Attachments (1)
📄pdf
Download →
32c06f4b-ef99-4ffc-b014-dda0732e436f.pdf
View document text
August 1, 2026
The Manager
Corporate Relationship Department
BSE Limited
Phiroze Jeejeebhoy Towers
Dalal Street, Fort
Mumbai – 400001
Scrip Code: 531015
Sub: Intimation of Board Meeting to be held on 07.08.2026
Dear Sir / Madam,
A Meeting of the Board of Directors of the company will be held on Friday, August 7, 2026 at 4.00
P.M, inter-alia to consider the following:
1. To consider and approve the Un-audited Financial Results of the Company for the Quarter ended
June 30, 2026.
2. To consider and approve the Forfeiture of partly paid-up share warrants.
Further, we wish to inform you that the Trading Window for dealing in Securities of the Company
which stands closed for all the Designated Persons of the Company with effect from July 1, 2026
would continue to remain closed till August 9, 2026 i.e., till 48 hours after the approval of the Un-
audited Standalone Financial Results of the Company for the Quarter ended June 30, 2026.
Kindly take the above information on record.
Thanking You
For Venmax Drugs and Pharmaceuticals Limited
Priyanka Agarwal
Company Secretary & Compliance Officer
Reg Office: Sy. No. 115, Brig Sayeed Road, Hanumanji Colony, Bowenpally, Picket, Hyderabad – 500009
CIN: L24230TG1988PLC009102 GSTIN: 36AAACY1073C3ZM
E-mail: venmaxdrugs@gmail.com